elynjacobs

Posts Tagged ‘Low Dose Naltrexone’

Cancer Deception

In Alternative Cancer Therapies, Alternatives Cancer Treatment, Anticancer foods, foods for colon cancer, foods for breast cancer, Breast Cancer, Cancer, cancer stem cells and recurrence, chemo and cancer stem cells, Healing Cancer Naturally, High Dose Vitamin C, targeting cancer stem cells on June 12, 2017 at 7:09 pm

By Elyn Jacobs and Dr. Michael Schachter

This article was originally written for and posted on  BeatCancer.org.

“Alternative treatment protocols have the potential to be competitive if not superior to conventional treatments. They should be considered as primary, not merely supplementary options for treatment.”  — Dr. Michael B. Schachter

If you don’t know your options, you don’t have any.”    —Elyn Jacobs, Cancer Coach

cancer deception

This past June, Dr. Michael Schachter presented at the 2016 International Conference: The Latest Developments in Integrative Cancer Therapies, held in Melbourne and Sydney, Australia. (He has been lecturing on this topic for years, throughout the United States and elsewhere.)

A major thesis of his presentation was that alternative treatment protocols have the potential to be competitive if not superior to conventional treatments. They should be considered as primary– not merely supplementary options for treatment.

Losing the Cancer War

Dr. Schachter stated we are losing the “war on cancer” as declared by President Nixon in the early 1970’s, with little improvement in the death rate and higher incidence of many cancers. The reason for this is that the cancer effort was really misfocused from the start. One problem is that there has been an emphasis on trying to cure cancer rather than on preventing it. Another problem is that treatment emphasized patent-able toxic drugs and radiation without paying sufficient attention to relatively non-toxic natural approaches like low dose Naltrexone,  IV Vitamin C, Salvestrols and others. Clearly, preventive strategies have worked for reducing the incidence and mortality of heart disease and stroke, but the medical establishment has put up severe resistance to the idea that we can best manage cancer by preventing it.

In fact, Dr. Schachter was quick to point out that despite the billions of dollars spent, there has been virtually no change in the death rates from cancer from 1950 to date. This is in stark contrast to the approximately 70% reduction in deaths from other conditions such as heart disease and stroke.

The Five-Year Survival Yardstick

Certainly, the five-year survival rate for cancer has increased, but that number is misleading—it provides no clue as to how many survivors are free of their disease. Included in this number are hundreds of thousands of people who will battle cancer to the five-year mark and beyond, only to have endured one toxic protocol after another. [Editor’s note: and frequently poor quality of life. Surviving is not the same as thriving!]

Furthermore, because diagnostic tests are finding more cancers at an early stage, more patients are being treated at an early stage. This translates to more patients making this five-year mark. However, this is at a stiff cost—for example, in the case of breast cancer, earlier benchmarking means more harmful testing and many unnecessary biopsies when something suspicious comes up on a mammogram. But a significant number of these early stage patients will be re-diagnosed as “late stage” six to ten years from their first diagnosis. And a patient who dies after a grueling six-year battle with cancer is nevertheless placed in the “survived” category because she has survived more than five years from the time of diagnosis. So you see, not only is the current standard of care not working, but the methodology of collecting statistics is flawed.

And although more patients are living longer today, only a small portion of that longevity has come from advances in conventional cancer treatment. Despite the endless procession of “wonder drugs,” the deadliest of cancers are still as deadly now as they were at the start of “the war.” 

Limits of Drug Therapy

What the failure of the “war on cancer” implies is that pretty much every agent in the fight against cancer—those myriad compounds that have set the research community abuzz and which have generated billions of dollars in profits — have had only a modest effect on long-term patient outcomes.

The latest progress in anti-cancer drugs seems to be with targeted therapies. This approach uses patented medications to inhibit or block biochemical pathways that play a role in cancer growth and spread. Most generics of these medications end in “mab” (monoclonal antibodies) or “nib” (small molecules). Examples are: Herceptin = Trastuzumab and Avastin = Bevacizumab (monoclonal antibodies) and Gleevec = Imatinib and Tarceva = Erlotinib (small molecules). The problem is that because there are many pathways within a cancer, these drugs have only limited effectiveness, and they also have undesirable side effects. Furthermore, since these pathways are used for normal cell functions as well, strong inhibition of a cancer pathway may cause severe complications in healthy cells. Moreover, many of these cancer pathways can be blocked with natural substances with much fewer side effects.

The cancer industry wants you to believe that its drugs are useful, and oncologists are joyful when a patient’s tumor shrinks on drug treatment. The problem is that shrinking tumors has little to do with improving the long-term survival of patients. It is not the initial tumor that kills people but rather the metastasis of the cancer cells. Aggressive cells break off from the primary tumor site and travel to the bones, brain, liver, lungs, or to some other vital area of the body. Even if an entire tumor is removed, and even if the nearby lymph nodes are negative for cancer, microscopic cells often recolonize elsewhere and are not found until later. According to Dr. Schachter, metastasis is what kills. [Editor’s note: Most cancer patients do not die from their disease at all, but rather from malnutrition, toxemia, and/or infections.]

Unfortunately, cancer treatments such as chemo and radiation not target the very cells responsible for metastases — the cancer stem cells – and in fact may encourage them to grow faster. This is one of the main reasons that conventional treatments like radiation and chemotherapy produce such poor results in the treatment of stage IV metastases (cancers that have spread to distant organs). A promising approach to this problem — though generally ignored by conventional oncologists — is the use of relatively non-toxic, anti-inflammatory herbs and nutrients. Substances that target cancer stem cells like black cumin, curcumin, broccoli extracts, vitamin D, and many others can play an important role. For more on this topic, please read Cancer Stem Cells and Progression of Disease: What You Need to Know Now.

Furthermore, we now know that conventional treatments sharply raise the risk for heart problems, stroke, and secondary cancers. Children are particularly at risk. Pediatric survivors have a six-fold greater risk of getting a second cancer, and adults face significant risk for complications as well.

No great insight is required to see that that our cancer-strategy is flawed. The ultimate problem lies in the cancer culture itself.

Challenging Traditional Views of Cancer

Surprisingly, decades ago some scientists viewed the cancer mechanism differently from the vast majority of cancer theorists. In recent years, the theory of cancer as outlined by Otto Warburg in the 1920’s has become more widely accepted. According to a written statement by Dr. Warburg,

“But nobody today can say that one does not know what cancer and its prime cause [are]. On the contrary, there is no disease whose prime cause is better known, so that today ignorance is no longer an excuse that one cannot do more about prevention. That prevention of cancer will come there is no doubt, for man wishes to survive. But how long prevention will be avoided depends on how long the prophets of agnosticism will succeed in inhibiting the application of scientific knowledge in the cancer field. In the meantime, millions of men must die of cancer unnecessarily.” [i]

— Dr. Otto Warburg, Medical Nobel Prize winner, Lindau, Germany, 1966

In 1986, John Bailar, a National Cancer Institute (NCI) statistician, also had the nerve to question the progress in the war on cancer, although he was severely ridiculed and shunned for doing so. In his 1986 paper “Progress Against Cancer?” Bailar argued that cancer research focuses too much on treatment and not enough on prevention, which would be far more effective. Then in 1997 in his paper “Cancer Undefeated” he concluded that “the effect of new treatments for cancer on mortality has been largely disappointing.”[ii]

In 1996, Michael Sporn, in an article printed in The Lancet, declared the war on cancer a failure. [iii] He predicted that the NCI would not achieve its stated target of a 50% reduction in cancer deaths by the year 2000. Sadly, he was right. Sporn believed that cancer could be chemically stopped, slowed, or reversed in its earliest pre-invasive stages. He even coined the widely-used term chemoprevention to distinguish cancer intervention from treatment. His was a truly radical idea in the cancer community.

Sporn’s goal was to dislodge the theory that cancer is something that just happens suddenly, that it is even a disease state. He did not subscribe to the idea that one either has cancer or not. Oncologists treat cancer, but logically, cancer is not an event of any kind. It does not suddenly happen upon diagnosis. It comes from years of dis-ease—it is a process. It begins when normal differentiation of a cell fails, when proper communication halts, and when the environment encourages cancer development. Long before cancer is detected, cancer is brewing—through a process known as carcinogenesis. It is nonsense to believe that the process has not been under way for many years.

Time for Change

Thankfully, our understanding of the nature of cancer and cancer treatment are in the process of undergoing major changes — though for economic and social reasons, there is tremendous resistance to these changes. Resistance comes from pharmaceutical companies, organized medicine, insurance companies, institutes of medical education, and the media. But if the path to cancer is something we can understand, why not treat it that way? It would be prudent to address the smoke before the fire burns down the house—to heal the patient at the very first signs of disease.

What if we could look at risk factors and markers, use diet instead of drugs, and use targeted supplements to prevent the development and progression of cancer? What if we were to heal the person with the cancer instead of just targeting the cancer? Surely, we would then stand a greater chance of winning the war. What if treatment for cancer patients started with a focus on lifestyle and nutritional changes? Considering that in many cases poor nutritional and lifestyle choices have contributed to the development of cancer, it would seem prudent to address such issues. Rather than just focusing on toxic conventional treatments, we could use various nutrients, herbs, and other non-toxic supplements in a synergistic way to improve the results with conventional treatment or, in some cases, instead of conventional treatment.

For sure, it is time to question the cancer strategy. It’s time for change.

For More Information

To view slides and notes from Dr. Schachter’s recent lectures, visit this link: http://www.schachtercenter.com/lecture_pdfs.htm

You may also want to view these two papers by Dr. Schachter:
“Integrative Oncology for Clinicians and Cancer Patients,” accessible at http://schachtercenter.com/IntegrativeOncologyISIMJournal.pdf  

”Integrating Nutrition and Selected Controversial Nutritional Supplements into a Cancer Treatment Program,” accessible at http://schachtercenter.com/ CSJARTICLE0001.PDF

Read more on Low Dose Naltrexone HERE.

Read more on why we are losing the War Against Cancer

Read more about High Dose Vitamin C HERE.

 

Dr. Michael B. Schachter is a magna cum laude graduate of Columbia College and Columbia P&S Medical School in NYC. He is also a Board-Certified Psychiatrist and a Certified Nutrition Specialist. Dr. Schachter has been involved with nutritional and integrative health care for over40 years. A leader in alternative cancer therapies, EDTA chelation and orthomolecular psychiatry, he is a past president of the American College of Advancement in Medicine (ACAM). He has authored numerous articles and was a major contributor to Burton Goldberg’s 1997 classic Alternative Medicine Definitive Guide to Cancer. In 2010, Dr. Schachter received the Humanitarian Award from the Cancer Control Society in California. He is the director of the Schachter Center for Complementary Medicine in Suffern, NY.

Elyn Jacobs is a breast cancer survivor and holistic cancer strategist who helps people make better, healthier, non-toxic choices. She specializes in understanding the role of estrogen in breast cancer and emphasizes the critical nature of addressing the root cause of cancer rather than its presenting symptoms. Elyn is a Contributing Editor for The Truth About Cancer and was creator and host of the Survive and Live Well Radio Show on the Cancer Support Network. Certified as a holistic cancer educator through BeatCancer.org, she serves on its Medical Advisory Board as well as on the Advisory Board for the Radical Remission Project. Elyn was formerly Executive Director of the Emerald Heart Cancer Foundation.

References:

[1] http://www.healthyfoodhouse.com/12-quotes-from-medical-doctors-that-the-cancer-treatment-industry-doesnt-want-you-to-read/ ; Dr Otto Warburg’s Cancer Research Papers

[2] http://www.nejm.org/doi/full/10.1056/NEJM199705293362206#t=article

[3] http://www.nejm.org/doi/full/10.1056/NEJM199705293362206#t=article; https://www.ncbi.nlm.nih.gov/pubmed/8637346

 

Elyn

~~If you don’t know your options, you don’t have any~~

Elyn Jacobs is a breast cancer survivor and holistic cancer strategist who helps people make better, healthier, non-toxic choices. She emphasizes the critical nature of addressing the root cause of cancer and not just its presenting symptoms (such as the tumor). Elyn specializes in understanding the role of estrogen in breast cancer and debunks the myths associated. She is a Contributing Editor for The Truth About Cancer and was creator and host of the Survive and Live Well Radio Show on the Cancer Support Network. Elyn is on the Medical Advisory Board for BeatCancer.Org and is on the Advisory Board to the Radical Remission Project. Elyn was the Executive Director of the Emerald Heart Cancer Foundation. Contact Elyn via her website, www.elynjacobs.com. Elyn offers consults via Skype, phone or in person.

Follow Elyn on Facebook
Follow Elyn on LinkedIn

Low Dose Naltrexone: The Affordable Non-Toxic Cancer Therapy Your Doctor is NOT Telling You About

In Alternative Cancer Therapies, Breast Cancer, Healing Cancer Naturally, Uncategorized on July 27, 2016 at 7:43 am

Naltrexone has been traditionally used to help drug and alcohol abusers.  But did you know that at very low doses, Naltrexone is a highly effective off-label therapy for cancer?

I rarely advocate for the use the pharmaceutical drugs, but low dose naltrexone (LDN) holds so much promise for those with cancer, that it virtues need to become known.

Naltrexone was approved by the FDA decades ago for opiate and alcohol dependence. And although the “off-label use” of a drug—prescribing it to treat conditions other than those for which it is approved—is perfectly legal, almost all doctors fail to do this. Sadly, most doctors refuse to consider any and all effective therapies that fall outside the mainstream. But this is a terrible disservice to those with cancer!

So why aren’t doctors prescribing it?  It comes down to money and ignorance.  In this case, the drug is cheap and the patent for naltrexone expired. Therefore there is no financial incentive for the drug company to advertise or push doctors to recommend it. Plus, or because of this and the resulting ignorance, many doctors take the stance that “if it were that good I would know about it”.

However, through the work of prominent doctors and researchers such as Dr Bernard Bihari MD, Dr Burt Berkson MD, and others, more and more researchers and patients are taking notice—and I suggest you do too!

The Birth of LDN as a Promising Therapy

Dr Bihari first started using naltrexone for his patients with addiction problems. He found that it worked well by attaching to the opioid receptors in the brain that heroin and other opiate drugs seek out.  In doing so, it blocks these receptors effectively preventing the ‘high’ that these drugs offer. However, during this time he found that naltrexone also blocked the binding of the body’s own endorphins and natural opiates that boost mood and sense of well-being. Thus, his patients felt terrible, so he stopped using the naltrexone.

However, through his work on AIDS Bihari found that at low doses given at bedtime, naltrexone stimulated endorphin release.  He found that endorphin levels doubled and often tripled which jumpstarted his patient’s immune systems— and the patients got better.

According to Dr Bihari, endorphins play a central role in immune function, and LDN enhances the immune response by stimulating endorphin production.

With this new development he began to focus on the immune system as a healing tool.  He found that LDN worked for other diseases linked to immune dysfunction such as MS — and cancer as well.

 How LDN Works

LDN revisedLDN works by blocking opioid receptors, which in turn helps activate the body’s immune system. It seems that when LDN is taken at bedtime, it binds to opioid receptors and temporarily blocks endorphins from attaching. This signals the body to increase endorphin production. The result is a dramatic boost in immune function. Then the opiates bind to receptors in bone marrow stem cells, macrophages, natural killer cells, T and B cells, and other immune cells and influence their development, differentiation, and function.

In other words, opioid receptors aren’t exclusive to the brain. They’re also present on all types of immune cells, including macrophages, natural killer cells, T- and B-cells, and even stem cells. As a result, the flood of endorphins set into motion by LDN stimulates the immune system and enhances the body’s ability to fight disease.

LDN upregulates opioid receptors in cancer cells, stimulating the process of programmed cell death (apoptosis) — thus killing some of the cancer cells.  It also stimulates certain immune cells that tend to go after cancer cells, including T4 and natural killer cells (NK cells).

Recent research also suggests that natural opiates also bind to receptors on cancer cells and inhibit their growth. LDN has been found to shrink tumors and inhibit their growth.

Major institutions such as The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have done considerable research on LDN.  Numerous case studies have shown it is effective for a variety of cancer types, including colon, prostate, melanoma, multiple myeloma, breast, ovary, uterine, brain, neuroblastoma, lung, Hodgkin’s disease, non-Hodgkin’s lymphoma, and chronic lymphocytic leukemia.

ALA and LDN, a Powerful Combination

There is also a combination therapy called the Berkson Method – using Alpha-Lipoic Acid alongside LDN. Lipoic acid is a potent antioxidant that neutralizes free radicals and generates and increases levels of vitamins C and E as well as CoQ10 and glutathione. Moreover, ALA is a modifier of gene expression. It seems to interfere with some of the genes that promote cancer. Note: look for R-ALA as it is the form found naturally occurring in the body and is the biologically active form of alpha lipoic acid. S-ALA is synthetic and should not be used.

Can I take LDN If I take Tamoxifen or Aromatase Inhibitors?

Several of my clients voiced their concerns about compatibility with aromatase inhibitors or tamoxifen. There are few reports of LDN interactions with other medications (do not use with opiate painkillers). Specifically though, according to Integrative Pharmacist David Restrepo, RPh (Vitahealth Apothecaries, New York), this should not be a problem with hormone therapies:

There is no data that suggests using AI’s, (regardless of the generation i.e. 1st 2nd or 3rd) and LDN cause any drug interaction. It’s important to keep a few things in mind.

Firstly, the normal dose of naltrexone is anywhere from 50-300mg daily and used as an opiate antagonist. Using this high of a dose would make there be a better chance of experiencing “side effects” but again, no drug interaction with AI’s. Secondly, naltrexone is selective to opiate receptors where AI’s are selective estrogen receptor modulators.

Lastly, they both are metabolized by the liver, BUT naltrexone, at such a low dose, is effective because it causes a “spike” in the bloodstream, where AI’s stay in the bloodstream much longer because of their relatively longer half-life. Any person worried about the possibility of drug interactions can just take their AI in the morning and the LDN AT NIGHT which is when it works best anyway. David Restrepo, RPh

What If I have Hashimoto’s, Graves or Another Autoimmune Disease?

One should always consult with a qualified doctor before taking any medication, but some people can actually achieve remission from autoimmune diseases by using LDN.  This is because LDN modulates the immune system.  It lowers inflammation as well as the immune reaction. However, if you have thyroid issues or any type of autoimmune disease, your doctor will likely start you out at a lower than normal dose.

Is LDN a Cure?

I’m not suggesting that LDN is a the magical cure for cancer, and in fact, it is not actually ‘curative’. This is partly because, like chemo and radiation,  it does not resolve the reason for the cancer.  But it is also is important to understand that LDN is a cell growth regulator. The goal is to regulate these cells and slow down the proliferation. Taken continuously, countless patients have achieved and maintained remission. Thus, in some cases,with the use of LDN cancer can be treated as a manageable chronic disease without the damaging effects of conventional chemotherapy and radiation–which on their own are rarely curative.

Therefore, I do recommend that you look into this safe, inexpensive ($25–30 a month) therapy. It may take some work convincing your doctor to write the script as this is an “off-label” use of an approved drug—but its long track record of efficacy makes it worth the effort. If you need some assistance with finding a doctor who will write the script, respond below in the comment field.

LDN requires a prescription and at is only available at compounding pharmacies. LDN must not be a timed-released preparation and should be taken at bedtime. The therapeutic dose ranges from 1.5-4.5mg, the later being the typical dose. Some people find that they have trouble sleeping or experience vivid dreams the first week taking LDN.  This issue should subside but consult with your doctor as he or she may want to reduce your dose for a week or so. If you have trouble filling your script, contact Vitahealth apothecary. www.vitahealthrx.com.

If you need something to back up your request to your doctor or just for more information, visit www.lowdosenaltrexone.org  to learn more as well as to find thousands of inspiring healing stories.

Again, I am not suggesting that LDN is the magical ‘cure-all’ for cancer, but it does offer a safe and inexpensive alternative to toxic cancer therapies. You might have to find an ‘outside the box’ doctor to prescribe this off-label drug, but it may well be worth the effort. If you would like to discuss how to incorporate LDN into your protocol, please contact me.

Lastly, this is something I have added to my own protocol. After all, who couldn’t use a few more  ‘feel good’ endorphins. For more of my story, please click here. It is not complete as far as supplements go, but that list is long.

 This information is for educational purposes only. It is not intended to treat, cure, prevent or diagnose any diseases or conditions. The information in this post does not represent medical advice, and I encourage you to discuss this information with your integrative oncologist or naturopathic doctor. Always consult with a medical doctor before you consider any prescription or over the counter drug or herb.

Read 12 Things a Cancer Doctor Should Never Say, my most recent article on The Truth About Cancer Website.

Elyn
~~If you don’t know your options, you don’t have any~~
Elyn Jacobs is a breast cancer survivor and holistic cancer strategist who helps people make better, healthier, non-toxic choices. She emphasizes the critical nature of addressing the root cause of cancer and not just its presenting symptoms (such as the tumor). Elyn specializes in understanding the role of estrogen in breast cancer and debunks the myths associated. She brings a plethora of knowledge to her practice and will help you think outside the box so you can incorporate every lifeline you may need for long term survival. Elyn is a Contributing Editor for The Truth About Cancer and was creator and host of the Survive and Live Well Radio Show on the Cancer Support Network. She is on the Medical Advisory Board for BeatCancer.Org and is on the Advisory Board to the Radical Remission Project. Elyn was the former Executive Director of the Emerald Heart Cancer Foundation. Contact Elyn via her website. Elyn offers consults via Skype, phone or in person.

Follow Elyn on Facebook

Follow Survive and Live Well on Twitter

Follow Elyn on Linkedin